Pages that link to "Q43666608"
Jump to navigation
Jump to search
The following pages link to Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV p24gag (Q43666608):
Displaying 50 items.
- Polymorphisms in the regulatory region of the Cyclophilin A gene influence the susceptibility for HIV-1 infection (Q28474342) (← links)
- Mapping of Linear B-Cell Epitopes on the Major Core Protein p24 of Human Immunodeficiency Virus Type 1 (HIV-1) (Q31146597) (← links)
- Multiple Antigenic Epitopes Expressed on gag Proteins, p26 and p15, of a Human Immunodeficiency Virus (HIV) Type 2 as Defined with a Library of Monoclonal Antibodies (Q33257532) (← links)
- Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays (Q33675677) (← links)
- Rapid escape from preserved cross-reactive neutralizing humoral immunity without loss of viral fitness in HIV-1-infected progressors and long-term nonprogressors (Q33725673) (← links)
- Infectious cellular load in human immunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmi (Q33781934) (← links)
- Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection (Q34044972) (← links)
- Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity (Q34195573) (← links)
- Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, VIDAS HIV DUO Ultra (Q34453624) (← links)
- Screening of HIV infection: role of molecular and immunological assays (Q34527302) (← links)
- HIV-1 replication fitness of HLA-B*57/58:01 CTL escape variants is restored by the accumulation of compensatory mutations in gag (Q35067451) (← links)
- Activity of broadly neutralizing antibodies, including PG9, PG16, and VRC01, against recently transmitted subtype B HIV-1 variants from early and late in the epidemic (Q35077704) (← links)
- Longer V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodies (Q35077797) (← links)
- Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages (Q35600426) (← links)
- Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient. (Q35634988) (← links)
- Longitudinal analysis of early HIV-1-specific neutralizing activity in an elite neutralizer and in five patients who developed cross-reactive neutralizing activity (Q35826458) (← links)
- ADAR1 Facilitates HIV-1 Replication in Primary CD4 T Cells (Q35858559) (← links)
- Susceptibility of recently transmitted subtype B human immunodeficiency virus type 1 variants to broadly neutralizing antibodies (Q38637805) (← links)
- Quantitative detection of human immunodeficiency virus (HIV) antigen by the Enzymun-Test: comparison with alternative assays and nucleic acid sequence-based amplification of HIV type 1 RNA (Q36533698) (← links)
- Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual (Q36684257) (← links)
- An anti-HIV-1 gag protein rat monoclonal antibody library (Q36796530) (← links)
- Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection (Q36845710) (← links)
- HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds (Q37073506) (← links)
- HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity. (Q37360774) (← links)
- Comparison of human immunodeficiency virus type 1 tropism profiles in clinical samples by the Trofile and MT-2 assays (Q37409937) (← links)
- Low level of HIV-1 evolution after transmission from mother to child (Q37738467) (← links)
- Genetic composition of replication competent clonal HIV-1 variants isolated from peripheral blood mononuclear cells (PBMC), HIV-1 proviral DNA from PBMC and HIV-1 RNA in serum in the course of HIV-1 infection (Q38415610) (← links)
- HIV-1 macrophage tropism is determined at multiple levels of the viral replication cycle (Q39009412) (← links)
- Proliferation-Dependent Replication in Primary Macrophages of Macrophage-Tropic HIV Type 1 Variants (Q39145168) (← links)
- Interference of interleukin-10 with human immunodeficiency virus type 1 replication in primary monocyte-derived macrophages (Q39145175) (← links)
- Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population (Q39439717) (← links)
- Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture (Q39439722) (← links)
- Comparison of in vivo and in vitro evolution of CCR5 to CXCR4 coreceptor use of primary human immunodeficiency virus type 1 variants (Q39597558) (← links)
- Cytopathic effects of non-syncytium-inducing and syncytium-inducing human immunodeficiency virus type 1 variants on different CD4( )-T-cell subsets are determined only by coreceptor expression (Q39604766) (← links)
- Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course (Q39605628) (← links)
- Equal levels of gp120 retention and neutralization resistance of phenotypically distinct primary human immunodeficiency virus type 1 variants upon soluble CD4 treatment (Q39868495) (← links)
- T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates (Q40217897) (← links)
- Adaptation of HIV-1 to rhTrim5α-mediated restriction in vitro (Q40429354) (← links)
- Productive HIV-1 infection of macrophages restricted to the cell fraction with proliferative capacity. (Q40794219) (← links)
- Fixation of cryo-sections under HIV-1 inactivating conditions: integrity of antigen binding sites and cell surface antigens. (Q41703014) (← links)
- Characterization of monoclonal antibodies directed against distinct conserved epitopes of human immunodeficiency virus type 1 core proteins (Q41725183) (← links)
- Differential expression of HIV-1 interfering factors in monocyte-derived macrophages stimulated with polarizing cytokines or interferons (Q42010307) (← links)
- Changing sensitivity to broadly neutralizing antibodies b12, 2G12, 2F5, and 4E10 of primary subtype B human immunodeficiency virus type 1 variants in the natural course of infection (Q44176443) (← links)
- Escape from autologous humoral immunity of HIV-1 is not associated with a decrease in replicative capacity. (Q44775993) (← links)
- Characterization of monoclonal antibodies identifying type and strain-specific epitopes of human immunodeficiency virus type 1 (Q44917676) (← links)
- The evolution of human immunodeficiency virus type-1 (HIV-1) envelope molecular properties and coreceptor use at all stages of infection in an HIV-1 donor-recipient pair (Q45361986) (← links)
- Escape of human immunodeficiency virus type 1 from broadly neutralizing antibodies is not associated with a reduction of viral replicative capacity in vitro. (Q45406304) (← links)
- Natural controlled HIV infection: preserved HIV-specific immunity despite undetectable replication competent virus (Q45440751) (← links)
- Multicenter evaluation of a new rapid automated human immunodeficiency virus antigen detection assay (Q45750021) (← links)
- Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay (Q45752772) (← links)